Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial
Article Details
Authors (26)
Zhigang Liu
State Key Laboratory of Chemical Biology
Dong Wang
Guanjun Li
Muhua Yi
Zhaoyuan Zhang
Guihua Zhong
Liangfu Xu
Rong Jiang
Yannan Zheng
Linxuan Huang
Yingpeng Peng
Lizhong Liang
Jianpeng Li
Institute of Photoelectronic Thin Film Devices and Technology, State Key Laboratory of Photovoltaic Materials and Cells, and Engineering Research Center of Thin Film Optoelectronics Technology, Ministry of Education , Nankai University, Tianjin 300350,
Ye Liu
Jun Lai
Department of Medicine, Johns Hopkins University School of Medicine
Xianjuan Lv
Yongqiang Xu
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology
Qiaodan Liu
Zhiqiang Wang
Zhutian Liu
Qinan Yang
Li Nie
Jiao Lei
Xiaotao Huang
Zhijie Liu
Wen Jiang